Great news! It appears that the deadlock between the Government and Lilly on the PBS listing of Emgality may have…
Continue Reading
A year too long
One year ago today, before Migraine Australia existed, the Pharmaceutical Benefits Advisory Committee – the independent body that recommends drugs…
Continue ReadingAimovig, Emgality and Ajovy are all now available on private script
All three CGRP antagonist monoclonal antibodies, Aimovig, Emgality and Ajovy, are all now available with a private prescription.
Continue Reading